Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

BUY
$96.41 - $126.61 $67,487 - $88,627
700 Added 40.98%
2,408 $248,000
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $36,024 - $48,801
304 Added 21.65%
1,708 $207,000
Q1 2023

May 01, 2023

BUY
$135.66 - $197.02 $13,566 - $19,702
100 Added 7.67%
1,404 $215,000
Q4 2022

Jan 25, 2023

BUY
$118.38 - $210.04 $154,367 - $273,892
1,304 New
1,304 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sfmg, LLC Portfolio

Follow Sfmg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.